Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care (NCT05204901) | Clinical Trial Compass
CompletedNot Applicable
Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care
Singapore10 participantsStarted 2022-05-04
Plain-language summary
This is a trial on the feasibility of magnetic tracking for the confirmation of nasogastric tube location in human patients.
Who can participate
Age range
21 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Patients from the general ward or the Otorhinolaryngology clinic of Tan Tock Seng Hospital who had an NGT inserted within the last 10 days and chest X-ray confirming its correct placement
* The NGT inserted is a Ryles tube size Fr 14 or 16
* COVID negative or not deemed to be infective as judged by the prevailing policies at the time of recruitment
* Age \> or = 21 years
* BMI \< 35
* Height \< 1.9m
* Mentally competent for informed consent
Exclusion Criteria:
* • Radiological:
* On chest X-ray, the length of the NGT distal to the gastroesophageal junction is less than 12cm, or the side-holes of the NGT can be visualized in the esophagus.
* The NGT is kinked within 10cm of its tip
* The chest X-ray is rotated such that the thorax is not oriented in the frontal plane
* The NGT cannot be visualized in the mediastinum
* The second intercostal space cannot be visualized on chest X-ray
• Medically unstable:
* Heart rate \>=100 or \<60
* Systolic blood pressure \>=160 or \<100
* SpO2 \<92% in patients with chronic lung disease and \<95% in patients without chronic lung disease
* Temperature \>= 38 degrees Celsius
• Chest wall deformity:
* Patients with pectus carinatum or excavatum, defined by physical examination
• Patients with the following implants
* Pacemaker
* Automatic cardioverter defibrillator
* Ferromagnetic coronary stents or heart valves
* Ferromagnetic implants of the cranium, face, spine, sternum o…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Probability of visualising a leftward deviation of the magnetic tipped guide-wire inferior to the xiphisternum
Timeframe: 6 months
2
Difference in the distance between the magnet and the datum with that between the nasogastric tube on chest X-ray and the datum